Sequester cuts scheduled for March 1st expected to impact healthcare, research

The healthcare industry, medical research and drug approval process are projected to be greatly affected by the federal budget cuts scheduled for March 1, according to a recent article on mondernhealthcare.com.  The Budget Control Act of 2011, originally scheduled to begin Jan. 2, required $1.2 trillion non-defense spending cuts over a 10 year period from federal programs.  With the delayed start, the effects of the budget may be worse with an “effective” 9% cut in nondefense program budgets. To read more details on how this affects the healthcare industry, click here.